Renal remission following conventional therapy in LN at 24 months of treatment.
| Renal Remission Criteria | Type of Response | n (%) |
|---|---|---|
| Ordinal mALMS | CR | 104 (59.1) |
| PR | 53 (30.1) | |
| None | 19 (10.8) | |
| Ordinal mBLISS-LN | CR | 72 (40.9) |
| PR | 29 (16.5) | |
| None | 75 (42.6) | |
| Binary mALMS* | Response | 109 (61.9) |
| None | 64 (36.4) | |
| Binary mBLISS-LN | Response | 101 (57.4) |
| None | 75 (42.6) |
↵* Three patients lacked sufficient data to be classified by binary mALMS criteria. LN: lupus nephritis; CR: complete remission; mALMS: modified Aspreva Lupus Management Study; mBLISS-LN: modified Belimumab International Lupus Nephritis Study; PR: partial remission.